Gasson Shelby B, Dobson Lauren K, Pfau-Cloud Michaela R, Beltran Felipe O, Pool Roy R, Gregory Carl A, Grunlan Melissa A, Saunders W Brian
Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
Department of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.
J Biomed Mater Res A. 2025 Jan;113(1):e37806. doi: 10.1002/jbm.a.37806. Epub 2024 Oct 15.
Biodegradable, shape memory polymer (SMP) scaffolds based on poly(ε-caprolactone) (PCL) offer unique advantages as a regenerative treatment strategy for critical-sized bone defects. In particular, a conformal fit may be achieved following exposure to warm saline, thereby improving osseointegration and regeneration. Advancing the clinical translation of these SMP scaffolds requires establishment of efficacy not only in non-loading models, but also load-bearing or load-sharing models. Thus, the present study evaluated the biocompatibility and bone regeneration potential of SMP scaffolds in a rabbit distal femoral condyle model. Two distinct SMP scaffold compositions were evaluated, a "PCL-only" scaffold formed from PCL-diacrylate (PCL-DA) and a semi-interpenetrating network (semi-IPN) formed from PCL-DA and poly(L-lactic acid) (PCL:PLLA). Semi-IPN PCL:PLLA scaffolds possess greater rigidity and faster rates of degradation versus PCL scaffolds. In vivo biocompatibility was assessed with a rat subcutaneous implantation model, whereas osseointegration was assessed with a 4 mm × 8 mm rabbit distal femoral condyle defect model. Both types of SMP scaffolds exhibited excellent biocompatibility marked by infiltration with fibrous tissue and a minimal inflammatory response. When implanted in the rabbit distal femur, both SMP scaffolds supported bone ingrowth. Collectively, these results demonstrate that the SMP scaffolds are biocompatible and integrate with adjacent host osseous tissues when implanted in vivo in a load-sharing environment. This study provides key proof-of-concept data necessary to proceed with large animal translational studies and clinical trials in human subjects.
基于聚(ε-己内酯)(PCL)的可生物降解形状记忆聚合物(SMP)支架作为治疗临界尺寸骨缺损的再生治疗策略具有独特优势。特别是,暴露于温盐水后可实现贴合,从而改善骨整合和再生。推进这些SMP支架的临床转化不仅需要在非负载模型中确立疗效,还需要在承重或负载分担模型中确立疗效。因此,本研究在兔股骨远端髁模型中评估了SMP支架的生物相容性和骨再生潜力。评估了两种不同的SMP支架组成,一种由PCL-二丙烯酸酯(PCL-DA)形成的“仅PCL”支架,以及一种由PCL-DA和聚(L-乳酸)(PCL:PLLA)形成的半互穿网络(半IPN)。与PCL支架相比,半IPN PCL:PLLA支架具有更高的刚性和更快的降解速率。通过大鼠皮下植入模型评估体内生物相容性,而通过4毫米×8毫米兔股骨远端髁缺损模型评估骨整合。两种类型的SMP支架均表现出优异的生物相容性,其特征是有纤维组织浸润且炎症反应最小。当植入兔股骨远端时,两种SMP支架均支持骨长入。总体而言,这些结果表明,SMP支架具有生物相容性,并且在负载分担环境中植入体内时可与相邻宿主骨组织整合。本研究提供了开展大型动物转化研究和人体临床试验所需的关键概念验证数据。